Thomas E. Delea
Impact in
- Genetics top 2%
- Hemoglobinopathies and Related Disorders
- Hematology top 5%
- Iron Metabolism and Disorders
Papers in
- Oncology 26
- Bone health and treatments 14
- Cancer Diagnosis and Treatment 9
- Co-authors
- May Hagiwara (36 shared papers)Gerry Oster (31 shared papers)John Edelsberg (18 shared papers)J. Brandman (13 shared papers)Pradyumna D. Phatak (9 shared papers)Oleg Sofrygin (14 shared papers)Simu K. Thomas (13 shared papers)Jennifer Sung (9 shared papers)
- Journals
- Blood (14 papers)Journal of Clinical Oncology (13 papers)Value in Health (12 papers)PharmacoEconomics (8 papers)Journal of Medical Economics (7 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Thomas E. Delea
131 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 112
- Genetics 351
- Hematology 322
- Oncology 544
- Family Practice 25
- Pulmonary and Respiratory Medicine 355
Countries citing papers authored by Thomas E. Delea
This map shows the geographic impact of Thomas E. Delea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Delea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Delea more than expected).
Fields of papers citing papers by Thomas E. Delea
This network shows the impact of papers produced by Thomas E. Delea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Delea. The network helps show where Thomas E. Delea may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas E. Delea, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 136 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 182 | |
| 2 | 2007 | 152 | |
| 3 | 1996 | 150 | |
| 4 | 2004 | 136 | |
| 5 | Retrospective study of the effect of skeletal complications on total medical care costs in patients with bone metastases of breast cancer seen in typical clinical practice. | 2006 | 85 |
| 6 | 2007 | 70 | |
| 7 | 1999 | 69 | |
| 8 | 2006 | 54 | |
| 9 | 2012 | 54 | |
| 10 | 2008 | 54 | |
| 11 | 2008 | 51 | |
| 12 | 2016 | 49 | |
| 13 | 2006 | 40 | |
| 14 | 2018 | 39 | |
| 15 | Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer. | 2006 | 38 |
| 16 | 1990 | 37 | |
| 17 | 1988 | 36 | |
| 18 | 2015 | 36 | |
| 19 | 2006 | 34 | |
| 20 | 2007 | 33 |
About Thomas E. Delea
Thomas E. Delea is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Genetics, Hematology and Economics and Econometrics, having authored 136 papers that have together received 2.5k indexed citations. Recurring topics across this work include Hemoglobinopathies and Related Disorders (16 papers), Bone health and treatments (14 papers), Management of metastatic bone disease (11 papers), Health Systems, Economic Evaluations, Quality of Life (11 papers), Multiple Myeloma Research and Treatments (10 papers), Cancer Diagnosis and Treatment (9 papers), Iron Metabolism and Disorders (8 papers) and Asthma and respiratory diseases (8 papers). The work is most often cited by research in Genetics (351 citations), Hematology (322 citations), Oncology (544 citations), Family Practice (25 citations) and Pulmonary and Respiratory Medicine (355 citations). Thomas E. Delea has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include May Hagiwara, Gerry Oster, John Edelsberg, J. Brandman, Pradyumna D. Phatak, Oleg Sofrygin, Simu K. Thomas, Jennifer Sung, Monika Raut and Jean‐François Baladi. Their work appears in journals such as Blood, Journal of Clinical Oncology, Value in Health, PharmacoEconomics and Journal of Medical Economics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.